AngioDynamics, Inc. (ANGO) Tops Q1 EPS by 1c; Lowers FY13 EPS outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Analysts Sees Synergies and Struggles in AngioDynamics' (ANGO) Latest Acquisition
October 9, 2012 10:41 AM EDTAngioDynamics (NASDAQ: ANGO) recently reported first quarter earnings, with revenue in line with guidance. ANGO also announced the acquisition of Vortex Medical.
"On the plus side, we see potentially positive synergies with ANGO's existing PV line. That said, the purchase price... More
